Amarin Corp Plc (AMRN)

[Stockpile4u]

Concerning the BRAVE trial or the anti-inflammatory properties of IPE, for example... Whether you like it or not, any new medical findings of IPE may help the relevant & respective patients in the long run, but will not help $AMRN in a big way anytime soon because $AMRN is a (WS) cursed company and is in the hands of bad management (both past and current). If BRAVE is positive, big Pharma should seize $AMRN immediately for further processing, such as planning or proposing a double blind test, etc. (preferably without using MO as a placebo this time!) and if the outcomes are positive, such as CVD RRR under Reduce IT, FDA approval, and so on. Those characteristics will enable Vascepa/Vazkepa attain its actual SP value, even if it is under a huge pharma at that point. I am confident that neither the previous nor present administration of $AMRN, nor Sarissa, can fulfill these goals.